Changes in nutritional status associated with unresectable pancreatic cancer. - Wikidata - awgldk - TriplyDB

Changes in nutritional status associated with unresectable pancreatic cancer.

Changes in nutritional status associated with unresectable pancreatic cancer.

http://www.wikidata.org/entity/Q36419986

about

Cancer cachexia Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour.What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: a systematic review and meta-analysis of randomized controlled trials Cachexia and pancreatic cancer: are there treatment options?The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature Functioning and health in patients with cancer on home-parenteral nutrition: a qualitative study.The anti-cachectic effect of fatty acids.The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.A pooled analysis of body mass index and pancreatic cancer mortality in african americans.Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.Nutritional status of patients with locally advanced pancreatic cancer: a pilot study.Famine versus feast: understanding the metabolism of tumors in vivo.Lipoxygenase inhibitors for the treatment of pancreatic cancer.Research methodology: cancer cachexia syndrome.Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients.A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting The Level of Serum Cholesterol is Negatively Associated with Lean Body Mass in Korean non-Diabetic Cancer Patients.Cancer cachexia prevention via physical exercise: molecular mechanisms.Changes in dietary intake, body weight, nutritional status, and metabolic rate in a pancreatic cancer patient The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer.Suppression of Tumor Growth and Muscle Wasting in a Transgenic Mouse Model of Pancreatic Cancer by the Novel Histone Deacetylase Inhibitor AR-42.Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.Reverse causation and illness-related weight loss in observational studies of body weight and mortality.A critical evaluation of body composition modalities used to assess adipose and skeletal muscle tissue in cancer.Care coordination to enhance management of long-term enteral tube feeding: a systematic review and meta-analysis.Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer.Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze.Palliative Pharmacotherapy: State-of-the-Art Management of Symptoms in Patients With Cancer.Pancreatic Fistula and Delayed Gastric Emptying After Pancreatectomy: Where do We Stand?Molecular Pathways: Cachexia Signaling-A Targeted Approach to Cancer Treatment.Risk factors for disability progression among Japanese long-term care service users: A 3-year prospective cohort study.Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.Pancreatic Exocrine Insufficiency in Pancreatic Cancer.Dietary intake after pancreatectomy.Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival.

P2860

Q21245747-889F4D28-501A-41A0-BECB-56E429ED6950 Q24685678-628EE5DA-0473-4DEF-9969-8D8D2BD3BE9A Q24811905-D0BC6879-0948-46C3-A640-58C09EB4FB26 Q26740239-83B00492-875D-49A0-AE52-4C99C2F93FCE Q27026558-7453D508-4186-48EA-877E-7B3A91976F5B Q28081125-B0CBFE70-2D43-4009-B8E5-1B2837FA71F1 Q30494289-D4CF8610-31D9-493C-99B7-6D48B79B9EE8 Q33545959-8B86AB01-A414-45F5-85E3-E003EB8AC6FD Q33874156-EB589B0E-F63E-4D94-8E81-C4865619EE14 Q33968290-55EE356F-EB25-4A8B-AC45-CC67A21476DB Q34031423-B0633B4D-2A99-4B2D-A67D-45246FD4DC5A Q34288054-B09CE6E6-46B9-41BC-B1A9-F1C40039B963 Q34315320-448D1CB8-DF2E-4A4F-8094-217806FE98B7 Q35112838-8539B9C4-6952-4A0E-9B78-E44967832DDE Q35122371-F6ADB7AA-4EB2-4BE6-8FF2-065338CE8358 Q35204970-8A4D3777-B52C-44B6-935D-92FB8E5031FD Q35872798-430677E5-D7B2-49A8-9892-1EB3454705F4 Q36074166-00431F36-4799-44A8-A28A-CE009CF33106 Q36671589-20CCD6B8-6E19-49A8-B551-D17EC487BC01 Q36686835-FC102590-D9E5-4227-AD13-FBDB7B3DD1B5 Q36864262-70208542-6F32-4B61-9227-73C7D7876227 Q36934986-516C41E7-FA4D-4731-8B3E-1265AD1F923B Q37057667-E1B8E398-8353-4E89-8C49-F4C36215DA78 Q37190293-D5D25F15-B9D0-4627-B6EF-97D5F8CF5B98 Q37447349-7E0BCE50-B86D-4340-8D55-ACFFA5E4C7DC Q37644886-4CFBCB62-BF17-49A0-AD43-79B17A4A7988 Q37702064-EEA486BA-5183-4621-836F-4B932181F1EE Q37808076-493EE416-B5E0-4C7E-A56F-5F00C1168AF9 Q38021854-389F93F0-E6B2-44AD-B432-0E3CC4C2ED11 Q38092935-1EBDC339-848F-4AC3-BC53-AEF731D8028B Q38244073-303E5DFF-93E3-4057-89CA-43356E7CEFEE Q38366834-BA1837E6-B8E3-437B-8C94-FC1837C5E1E4 Q38672357-9885671C-D6AC-4B62-A917-B1B1076901D3 Q38684607-3F11038B-AC7A-4903-A917-3BE1F2F9FFF5 Q38875788-5086DC69-E99A-4668-9700-255C5C4C8964 Q38878412-6C218657-CD55-4210-8C54-C7016D9B807C Q38968145-FB0EBA54-ECF5-4163-8AE7-964AC3F13F36 Q39152875-7AF7078E-5240-4099-8FFF-C6CFA854332E Q39499329-9E3E7F20-92CF-4C0F-9A58-02FB0E038DD2 Q40059776-C01269C9-9AAB-4780-B5E7-C1EBA45F9A33

P2860

Changes in nutritional status associated with unresectable pancreatic cancer.

http://www.wikidata.org/entity/Q36419986

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh

1997年學術文章

@zh-hant

name

Changes in nutritional status associated with unresectable pancreatic cancer.

@ast

Changes in nutritional status associated with unresectable pancreatic cancer.

@en

type

label

Changes in nutritional status associated with unresectable pancreatic cancer.

@ast

Changes in nutritional status associated with unresectable pancreatic cancer.

@en

prefLabel

Changes in nutritional status associated with unresectable pancreatic cancer.

@ast

Changes in nutritional status associated with unresectable pancreatic cancer.

@en

P1433

Q36419986-6A2BD16B-75A1-40DB-B4DA-251E51C6DD9A

P1476

Q36419986-0DBE9738-6A0B-4B7C-8887-7DEE65297F5F

P2093

Q36419986-2C8E94A9-C569-4C96-A6C2-86AD717883A8

Q36419986-600543BE-7371-4FFC-8B9F-8A33416D20CC

Q36419986-74E89A36-02D2-405D-B495-5C6314EDA1C0

Q36419986-7EBFEE2E-783A-45C9-B80B-BAB35595E795

P2860

Q36419986-03DCDEC7-3B07-4617-ABA1-772F0EAEAA02

Q36419986-3B33742F-82FC-4A81-97F0-4BFC9942F414

Q36419986-3C92D05D-DCE6-4395-ABBF-9BB0A14DCA8B

Q36419986-443313A8-7B3E-48D2-AC1D-86AC1DD51A70

Q36419986-59BC2EF7-C817-4FE4-BB3D-A2CBC89DD3AB

Q36419986-614231DB-60D0-4634-88FA-A6988AA14E19

Q36419986-6C5577A0-AFC6-4187-AE79-6087DFF7FAA1

Q36419986-6D8D3AC6-D218-47E1-BF10-69FCACD8CF3E

Q36419986-81553FD3-4912-4163-9FEB-CD16E18D9A68

Q36419986-85E8E22E-CBA1-4503-A0B5-BCCFC8B8E881

P2888

Q36419986-7433CECB-B36C-4B43-8EF0-45B3C51BDA7F

P304

Q36419986-FE15EEF6-6D06-4466-B9A9-E728652BFD55

P31

Q36419986-DFFD840D-5C7E-4920-BD69-DD5F4F748E08

P356

Q36419986-92713830-7565-4D3D-8834-DF5EB9A04547

P407

Q36419986-67A2E32A-9224-448B-B3A6-38D1571E67B4

P433

Q36419986-F75E2759-A37D-41E5-832F-343FE31F1D88

P478

Q36419986-475E4214-B121-42DE-823C-8FA535A1E316

P577

Q36419986-A7103990-1FBE-4EB3-9638-4CB3D78D80B1

P5875

Q36419986-E8C61341-B95A-4974-8077-318625C02320

P6179

Q36419986-E32B5341-C76C-4E87-BD91-0BF78B879EF7

P698

Q36419986-AA5F5205-312D-447B-AA8D-29D01E97EACD

P932

Q36419986-70720724-9E0C-4DF3-B0EA-13087BAEF6D7

P356

P1433

British Journal of Cancer

P1476

Changes in nutritional status associated with unresectable pancreatic cancer.

@en

P2093

Fearon KC

http://www.w3.org/2001/XMLSchema#string

Plester CE

http://www.w3.org/2001/XMLSchema#string

Richardson RA

http://www.w3.org/2001/XMLSchema#string

Wigmore SJ

http://www.w3.org/2001/XMLSchema#string

P2860

Proceedings: Causes of death in cancer patients.

Muscle function and nutrition.

Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients

Validity of anthropometric norms used in the assessment of hospitalized patients.

Body composition research at the University of Auckland--some implications for modern surgical practice.

Body composition in chronic undernutrition.

Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.

Body composition in cancer cachexia.

Weight loss with physiologic impairment. A basic indicator of surgical risk.

Body composition analysis: an evaluation of 2 component models, multicomponent models and bedside techniques.

P2888

P304

106-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1997.17

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P577

1997-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14207023

http://www.w3.org/2001/XMLSchema#string

P6179

1014461719

http://www.w3.org/2001/XMLSchema#string

P698

9000606

http://www.w3.org/2001/XMLSchema#string

P932

2222706

http://www.w3.org/2001/XMLSchema#string